Peptide vaccines

thumb|A poster advertising trials of the RTS,S vaccine RTS,S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine. It is one of two malaria vaccines approved (the other is R21/Matrix-M). , the vaccine has been given to 1million children living in areas with moderate-to-high malaria transmission, with millions more doses to be provided as the vaccine's production expands. 18 million doses have been allocated for 2023–2025. It requires at least three doses in infants by age 2, with a fourth dose extending the protection for another 1–2 years. The vaccine reduces hospital ad

UB-612 is a COVID-19 vaccine candidate developed by , and Vaxxinity, Inc. It is a peptide vaccine.

peptide which serves to immunize an organism against a pathogen